Stryker Corporation — Earnings Quality Grade F
SYK · Healthcare
Major red flags
Screening Summary
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 59 days, change -6 days YoY
AR growth 1.3% vs revenue growth 11.2%
Revenue 11.2%, CFFO 18.9%. Cash follows revenue
Expense Quality
Inventory 11.2% vs COGS 11.0%. Normal
CapEx growth 0.8% vs revenue 11.2%. Normal
SG&A/Gross Profit = 53.8%. Normal
Gross margin 64.0%, change +0.1pp. Stable
Cash Flow Quality
CFFO/NI = 1.55. Profits backed by cash
FCF $4.3B, FCF/NI = 1.32
Accruals ratio = -3.8%. Low accruals
Cash $4.1B covers only 26% of debt $15.9B
Balance Sheet Health
Goodwill+Intangibles $25.0B = 111% of equity. Over 50%
Debt/EBITDA = 2.5x. Healthy
Other assets 17.1% vs revenue 11.2%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 23% YoY. Normal
Manipulation Score
M-Score = -2.62 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-09